Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

- Biomedical Research (2016) Volume 27, Issue 2

Influence of recombinant human Endostatin on the expression of ERCC1 in human lung adenocarcinoma A549 cells.

Objective: To investigate the effect of Endostar and/or DDP on the expression of ERCC1 gene and to provide help to the secondary treatment of lung cancer.

Methods: Human lung adenocarcinoma A549 cells were treated by DDP and rh-Endostatin. MTT method was used for detecting growth inhibition of A549 cells by Rh-Endostatin, DDP and combination of both drugs to determine the applied concentration.

Results: 1. By MTT method,Rh-Endostatin had no cytotoxic effect on A549 cells at the concentration of 300 μg/ml. IC30 of DDP to A549 cells was 0.34 μg/ml, and IC30 of DDP in combination with Rh-Endostatin to A549 cells was 0.13 μg/ml. 2. By real time PCR, mRNA relative expression of ERCC1 genes in each group were as follows: (i)1.00; (ii)0.88; (iii) 2.00; (iv)1.90; (v)0.77.The resulting: (1) Expression in all treatment groups was higher than that in control group. (2) Expression in combination treatment groups was higher than those in single-drug treatment group.

Conclusions: 1. Cytotoxic effect of DDP to lung adenocarcinoma A549 cells is enhanced by Rh-Endostatin. 2. Expression of ERCC1 mRNA in A549 cells is enhanced in combination treatment by DDP and Rh-Endostatin.

Author(s): Yu Xuan Che, Yan Yan, Xiu Hua Sun

Abstract Full Text PDF

Get the App